Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-060970

Chief Medical Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Pang Phillip Chief Medical Officer 2020-11-27 Option exercise +7,500 $0.86 $6,413 57,277 D
Derivatives
Pang Phillip Chief Medical Officer 2020-11-27 Option exercise · Employee Stock Option (Right to Buy) −7,500 53,833 D
Loading xslF345X03/doc4.xml…